BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report)’s stock price dropped 3.8% during trading on Thursday . The stock traded as low as $0.87 and last traded at $0.91. Approximately 62,883 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 55,024 shares. The stock had previously closed at $0.95.
Analyst Ratings Changes
Separately, HC Wainwright restated a “buy” rating and set a $2.00 price objective on shares of BiomX in a research note on Wednesday, January 8th.
Read Our Latest Research Report on PHGE
BiomX Trading Down 3.8 %
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Read More
- Five stocks we like better than BiomX
- The Significance of Brokerage Rankings in Stock Selection
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Consumer Staples Stocks, Explained
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
